DE69525349D1 - Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert - Google Patents

Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert

Info

Publication number
DE69525349D1
DE69525349D1 DE69525349T DE69525349T DE69525349D1 DE 69525349 D1 DE69525349 D1 DE 69525349D1 DE 69525349 T DE69525349 T DE 69525349T DE 69525349 T DE69525349 T DE 69525349T DE 69525349 D1 DE69525349 D1 DE 69525349D1
Authority
DE
Germany
Prior art keywords
sclacing
macrophage
infiltration
treatment
sclacing associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69525349T
Other languages
English (en)
Other versions
DE69525349T2 (de
Inventor
Anne Turley
Simon Asculai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Application granted granted Critical
Publication of DE69525349D1 publication Critical patent/DE69525349D1/de
Publication of DE69525349T2 publication Critical patent/DE69525349T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69525349T 1994-08-24 1995-08-02 Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert Expired - Lifetime DE69525349T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002130762A CA2130762C (en) 1994-08-24 1994-08-24 Treatment of disease and conditions associated with macrophage infiltration
PCT/CA1995/000467 WO1996005845A2 (en) 1994-02-23 1995-08-02 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction

Publications (2)

Publication Number Publication Date
DE69525349D1 true DE69525349D1 (de) 2002-03-21
DE69525349T2 DE69525349T2 (de) 2002-10-31

Family

ID=4154227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69525349T Expired - Lifetime DE69525349T2 (de) 1994-08-24 1995-08-02 Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert

Country Status (14)

Country Link
EP (1) EP0777487B1 (de)
JP (1) JP4111537B2 (de)
KR (1) KR970705402A (de)
CN (1) CN1131539A (de)
AP (1) AP619A (de)
AT (1) ATE212850T1 (de)
AU (1) AU701014B2 (de)
CA (1) CA2130762C (de)
DE (1) DE69525349T2 (de)
ES (1) ES2172589T3 (de)
HU (1) HUT76895A (de)
IL (1) IL114915A0 (de)
WO (1) WO1996005845A2 (de)
ZA (1) ZA957056B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
EP0914133B1 (de) * 1996-03-14 2003-07-23 The Governors Of The University Of Alberta Verwendung von hyaluronsäure zur zellmobilisierung
US6875753B1 (en) 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
JP4771563B2 (ja) 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Ｉｌ−１媒介疾患を処置するためにｉｌ−１インヒビターを使用する組合せ療法
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
DE60034667T2 (de) * 1999-02-01 2008-03-13 Dermal Research Laboratories, Inc. Pharmazeutische zusammensetzung aus komplexen kohlenhydraten und deren anwendung
WO2000054762A2 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Use of cross linked polysaccharides for the inhibition of angiogenesis
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
TWI758928B (zh) 2014-11-21 2022-03-21 美商必治妥美雅史谷比公司 抗cd73抗體及其用途
EP3675862A4 (de) * 2017-09-01 2021-06-09 Excel Med, LLC Viskose zusammensetzung zur behandlung von ischämie
WO2019050893A1 (en) * 2017-09-05 2019-03-14 Excel Med, Llc HEPARIN COMPOSITION FOR THE TREATMENT OF ISCHEMIA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498524B1 (fr) * 1981-01-27 1986-07-25 Thomson Csf Dispositif electromecanique d'impression pour imprimante du type serie-parallele et telecopieur comportant un tel dispositif
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US4725585A (en) * 1985-04-26 1988-02-16 Pharmacia Ab Method of enhancing the host defense
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
AU3721793A (en) * 1992-02-24 1993-09-13 Paul L. Simmons Biodegradable germicide

Also Published As

Publication number Publication date
KR970705402A (ko) 1997-10-09
WO1996005845A2 (en) 1996-02-29
WO1996005845A3 (en) 1996-04-11
CN1131539A (zh) 1996-09-25
ATE212850T1 (de) 2002-02-15
AP619A (en) 1997-10-10
AU3107095A (en) 1996-03-14
CA2130762A1 (en) 1996-02-25
DE69525349T2 (de) 2002-10-31
AU701014B2 (en) 1999-01-21
ES2172589T3 (es) 2002-10-01
IL114915A0 (en) 1995-12-08
AP9500757A0 (en) 1995-10-31
JPH10506884A (ja) 1998-07-07
JP4111537B2 (ja) 2008-07-02
ZA957056B (en) 1996-03-26
EP0777487B1 (de) 2002-02-06
HUT76895A (en) 1997-12-29
CA2130762C (en) 1999-07-06
EP0777487A1 (de) 1997-06-11

Similar Documents

Publication Publication Date Title
ATE331505T1 (de) Behandlung einer hämoglobinstörung
ATE174792T1 (de) Mit einer wasser-in-lipid emulsion behandelte reinigungstücher
DK0664957T3 (da) Behandling af fjerkræ
DE69513916D1 (de) Oberflächenbehandlungszusammensetzung
BR9502092A (pt) Conjunto de fechaduras
DE69525349D1 (de) Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert
DE69619051T2 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
DE69306260D1 (de) Behandlung von abwasser
DE69125179D1 (de) Abwassersbehandlung
FI945200A (fi) Jäteveden puhdistus
DE59304835D1 (de) Waschverfahren
DK111690A (da) Vandbehandlingsindretning
ATA252792A (de) Tieftemperatur - isolation und mit einer solchen versehene gegenstaende
KR950022699U (ko) 화장실용 욕조
FI971888A0 (fi) Ohjausaste
ATA75393A (de) Sprudelwanne
KR950005763U (ko) 용수처리기
KR960020156U (ko) 각탕기
KR950026621U (ko) 욕 조
FI921906A0 (fi) Faestanordning foer konstvagina.
LV10005A (lv) Udens apstradasanas panemiens
FI68U1 (fi) Tub
ITUD920028A1 (it) Procedimento di essicamento/sterilizzazione mediante applicazione di microonde
SE9203312D0 (sv) Variabelt badkar
KR940002743U (ko) 가정용 사우나기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition